HST5040
- Generic Name
- HST5040
Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia
Phase 2
Terminated
- Conditions
- Methylmalonic AcidemiaPropionic Acidemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- HemoShear Therapeutics
- Target Recruit Count
- 26
- Registration Number
- NCT04732429
- Locations
- 🇺🇸
Rady Children's Hospital, San Diego, California, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath